← Open Payments lookup

SARAH MONCEAUX: Open Payments

NPI 1356727796 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,050 in 127 payments from 15 companies in 2025. Trend: 2023 $641 · 2024 $852 · 2025 $2,050

Food & beverage: $2,050
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.30$421
ABBVIE INC.20$285
Alkermes, Inc.19$250
Neurocrine BioSciences, Inc.7$161
Axsome Therapeutics, Inc.11$159
Teva Pharmaceuticals USA, Inc.10$139
Janssen Pharmaceuticals, Inc7$135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$117
Vanda Pharmaceuticals Inc.5$113
E.R. Squibb & Sons, L.L.C.3$70

Products named: VRAYLAR, REXULTI, ARISTADA, ABILIFY ASIMTUFII, INGREZZA, Auvelity, CAPLYTA, FANAPT.

Industry payments across LA — which companies pay providers there.